CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-20 | Prasad Raju Chief Financial Officer | Option exercise | +6,250 | 19,273 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +38,499 | 38,499 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Grant or award · Restricted Stock Units | +27,500 | 27,500 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Option exercise · Restricted Stock Units | −6,250 | 12,500 | ||
| 2026-03-20 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,499 | 38,499 | ||
| 2026-03-20 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2026-03-16 | Patel Naimish Chief Medical Officer | Sale | −3,150 | $48.26 | $152K | 13,143 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −5,848 | $48.26 | $282K | 17,794 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −4,021 | $48.26 | $194K | 13,773 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Gift | −750 | 13,023 | ||
| 2026-03-16 | KASINGER JAMES R. General Counsel and Secretary | Sale | −3,450 | $48.26 | $166K | 91,240 |
| 2026-03-16 | Kulkarni Samarth Chief Executive Officer | Sale | −10,349 | $48.26 | $499K | 245,834 |
| 2026-03-14 | Patel Naimish Chief Medical Officer | Option exercise | +8,125 | 16,293 | ||
| 2026-03-14 | Patel Naimish Chief Medical Officer | Option exercise · Restricted Stock Units | −8,125 | 24,375 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Option exercise | +10,000 | 16,767 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Option exercise | +6,875 | 23,642 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Option exercise · Restricted Stock Units | −10,000 | 10,000 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Option exercise · Restricted Stock Units | −6,875 | 20,625 | ||
| 2026-03-14 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +6,875 | 94,690 | ||
| 2026-03-14 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −6,875 | 20,625 |
Page 4 of 46 · 910 trades